SARS-CoV-2 infection among patients with cancer undergoing antitumor treatment

What The Study Did:

The rate of SARS-CoV-2 infection among patients in Italy receiving antitumor treatment was evaluated in this study.

Authors:

Carlo Aschele, M.D., Ph.D., of Ospedale Sant’Andrea in La Spezia, Italy, is the  corresponding author.

To access the embargoed study:

Visit our For The Media website at this link

https:/

(doi:10.1001/jamaoncol.2020.6778)

Editor’s Note:

The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:

The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

121720